We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+19.4%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$875B
AUM Growth
+$257B
Cap. Flow
+$103B
Cap. Flow %
11.73%
Top 10 Hldgs %
22.67%
Holding
15,447
New
2,575
Increased
6,089
Reduced
4,803
Closed
1,872

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$9.91B
2
SPCX
SpaceX
SPCX
+$871M
3
LLY icon
Eli Lilly
LLY
+$719M
4
AMZN icon
Amazon
AMZN
+$698M
5
NFLX icon
Netflix
NFLX
+$627M

Sector Composition

Rank Sector Weight
1 Technology 3.92%
2 Healthcare 2.55%
3 Industrials 2.24%
4 Financials 2.13%
5 Consumer Discretionary 1.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWBC
4376
Community West Bancshares
CWBC
$708M
$5.95M ﹤0.01%
221,531
+211,504
+2,109% +$5.15M
FCFS icon
4377
CALL
FirstCash
FCFS
$9.31B
$5.95M ﹤0.01%
27,500
+16,100
+141% +$3.5M
CGCB icon
4378
Capital Group Core Bond ETF
CGCB
$5.77B
$5.95M ﹤0.01%
227,177
-55,709
-20% -$1.46M
CRVS icon
4379
Corvus Pharmaceuticals
CRVS
$1.25B
$5.95M ﹤0.01%
397,951
-44,571
-10% -$619K
OPER icon
4380
ClearShares Ultra-Short Maturity ETF
OPER
$105M
$5.94M ﹤0.01%
+59,397
New +$5.95M
ARMK icon
4381
CALL
Aramark
ARMK
$16.4B
$5.93M ﹤0.01%
104,300
+56,200
+117% +$2.77M
ST icon
4382
Sensata Technologies
ST
$6.73B
$5.93M ﹤0.01%
124,209
+92,293
+289% +$4.17M
ARR
4383
Armour Residential REIT
ARR
$2.37B
$5.93M ﹤0.01%
339,735
-316,047
-48% -$5.44M
FMC icon
4384
FMC
FMC
$1.27B
$5.93M ﹤0.01%
515,394
+401,644
+353% +$5.6M
MRCY icon
4385
CALL
Mercury Systems
MRCY
$6.67B
$5.92M ﹤0.01%
48,400
-1,200
-2% -$114K
JETS icon
4386
US Global Jets ETF
JETS
$824M
$5.92M ﹤0.01%
178,202
+7,166
+4% +$198K
TAP icon
4387
CALL
Molson Coors Class B
TAP
$7.97B
$5.92M ﹤0.01%
151,900
-150,000
-50% -$6.27M
UHS icon
4388
PUT
Universal Health Services
UHS
$10B
$5.92M ﹤0.01%
39,800
+25,600
+180% +$4.16M
ARTV
4389
Artiva Biotherapeutics
ARTV
$560M
$5.91M ﹤0.01%
609,376
+593,506
+3,740% +$5.41M
MCRI icon
4390
Monarch Casino & Resort
MCRI
$2.22B
$5.91M ﹤0.01%
44,884
-39,388
-47% -$4.59M
INCY icon
4391
PUT
Incyte
INCY
$24.4B
$5.91M ﹤0.01%
52,100
+13,500
+35% +$1.34M
JNUG icon
4392
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$534M
$5.9M ﹤0.01%
48,900
+6,600
+16% +$1.19M
VFC icon
4393
CALL
VF Corp
VFC
$5.85B
$5.9M ﹤0.01%
353,600
-118,500
-25% -$2.12M
HSAI
4394
Hesai Group
HSAI
$2.86B
$5.9M ﹤0.01%
323,663
+237,081
+274% +$4.85M
METU
4395
PUT
Direxion Daily META Bull 2X ETF
METU
$457M
$5.89M ﹤0.01%
290,700
+158,200
+119% +$3.94M
LXFR icon
4396
Luxfer Holdings
LXFR
$457M
$5.88M ﹤0.01%
326,110
+51,650
+19% +$806K
AGX icon
4397
Argan
AGX
$8.11B
$5.87M ﹤0.01%
7,355
-60,654
-89% -$40.4M
VSNT
4398
CALL
Versant Media Group
VSNT
$5.52B
$5.87M ﹤0.01%
163,000
-36,288
-18% -$1.46M
LLYVK icon
4399
CALL
Liberty Live Group Series C
LLYVK
$10B
$5.86M ﹤0.01%
+55,500
New +$5.41M
TVTX icon
4400
CALL
Travere Therapeutics
TVTX
$5.86B
$5.86M ﹤0.01%
103,200
-96,400
-48% -$4.27M

Similar funds

Ken Griffin's Q2 2026 Portfolio in Review

As of Q2 2026, Ken Griffin held 15,447 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin deployed $103B of net new capital in Q2 2026, opening 2,575 new positions and adding to 6,089 existing holdings. Its largest new stake was SpaceX: 5,129,884 shares worth $876M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, down from 4.5% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Micron Technology, an estimated $3B trimmed.

  • Ken Griffin's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
  • Ken Griffin's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
  • Ken Griffin fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
  • Ken Griffin's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
  • Ken Griffin opened 2,575 new positions and closed 1,872 in Q2 2026.
  • Ken Griffin's portfolio value rose 41% quarter-over-quarter to $875B.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.